Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Overactive bladder (OAB) is a common and troublesome condition that can significantly impair quality of life. This review aims to educate providers of obstetrics and gynecology services about available therapies for OAB and what to expect following treatment. Here, we review published data from studies that have evaluated available treatments for OAB. Relevant articles published over the past 2 decades, including large multicenter trials, were identified through a literature search using PubMed.gov, and the references in those articles were also manually searched to find additional articles. Treatment guidelines and product labels were also reviewed. Behavioral therapy is recommended as a first choice for OAB management; pharmacologic treatment (anticholinergics, β3 -adrenoceptor agonists) as second-line treatment; and onabotulinumtoxinA, peripheral tibial nerve stimulation, and sacral nerve stimulation as third-line therapy for patients refractory or intolerant to first- and second-line treatments. A stepwise approach to treatment through first-, second-, and third-line therapies is recommended, recognizing this may not be appropriate for all patients. To optimize symptom control and set realistic expectations, patients should be carefully monitored and counseled appropriately on available treatment options. © 2021 Japan Society of Obstetrics and Gynecology.

Citation

Victor W Nitti, Anand Patel, Mickey Karram. Diagnosis and management of overactive bladder: A review. The journal of obstetrics and gynaecology research. 2021 May;47(5):1654-1665

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 33592680

View Full Text